2159 related articles for article (PubMed ID: 15936776)
1. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
Bitar MS; Al-Saleh E; Al-Mulla F
Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
[TBL] [Abstract][Full Text] [Related]
2. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
Bitar MS
Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
[TBL] [Abstract][Full Text] [Related]
3. Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats.
Bitar MS; Wahid S; Pilcher CW; Al-Saleh E; Al-Mulla F
Horm Metab Res; 2004 Aug; 36(8):542-9. PubMed ID: 15326564
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats.
Dadke SS; Li HC; Kusari AB; Begum N; Kusari J
Biochem Biophys Res Commun; 2000 Aug; 274(3):583-9. PubMed ID: 10924321
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
Wu Y; Ouyang JP; Zhou YF; Wu K; Zhao DH; Wen CY
Sheng Li Xue Bao; 2004 Aug; 56(4):539-49. PubMed ID: 15322693
[TBL] [Abstract][Full Text] [Related]
6. New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
Bergman RN
Recent Prog Horm Res; 1997; 52():359-85; discussion 385-7. PubMed ID: 9238859
[TBL] [Abstract][Full Text] [Related]
7. Effect of a 2-day very low-energy diet on skeletal muscle insulin sensitivity in obese type 2 diabetic patients on insulin therapy.
Jazet IM; Ouwens DM; Schaart G; Pijl H; Keizer H; Maassen JA; Meinders AE
Metabolism; 2005 Dec; 54(12):1669-78. PubMed ID: 16311102
[TBL] [Abstract][Full Text] [Related]
8. Infusion of beta-endorphin improves insulin resistance in fructose-fed rats.
Su CF; Chang YY; Pai HH; Liu IM; Lo CY; Cheng JT
Horm Metab Res; 2004 Aug; 36(8):571-7. PubMed ID: 15326568
[TBL] [Abstract][Full Text] [Related]
9. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation.
Moon B; Kwan JJ; Duddy N; Sweeney G; Begum N
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E106-15. PubMed ID: 12618360
[TBL] [Abstract][Full Text] [Related]
10. Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling.
Choi CS; Kim YB; Lee FN; Zabolotny JM; Kahn BB; Youn JH
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E233-40. PubMed ID: 12110527
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of insulin-resistant glucose utilization in rat skeletal muscle.
Rizk NM; Meier DA; Krakower GR; Kissebah AH
Mol Genet Metab; 1998 Feb; 63(2):126-33. PubMed ID: 9562966
[TBL] [Abstract][Full Text] [Related]
12. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
13. Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus.
Shao J; Catalano PM; Yamashita H; Ishizuka T; Friedman JE
Am J Obstet Gynecol; 2000 Nov; 183(5):1263-70. PubMed ID: 11084576
[TBL] [Abstract][Full Text] [Related]
14. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
15. No in vitro effects of fatty acids on glucose uptake, lipolysis or insulin signaling in rat adipocytes.
Lundgren M; Eriksson JW
Horm Metab Res; 2004 Apr; 36(4):203-9. PubMed ID: 15114517
[TBL] [Abstract][Full Text] [Related]
16. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
Park E; Wong V; Guan X; Oprescu AI; Giacca A
J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
[TBL] [Abstract][Full Text] [Related]
18. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
[TBL] [Abstract][Full Text] [Related]
20. [Research of the relationship between insulin signal transduction and glucose transportation in rats after trauma].
Jiang Y; Wu GH
Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):214-7. PubMed ID: 19563078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
